Skip to content
10-Q/A

Quarterly Report

NORTHERN GENESIS ACQUISITION CORP. III

0001213900-22-028908

← back to feed
Filed
May 23, 2022 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Nov 19, 2021 21.56M sh
Operating Cash Flow Q3 2021 · Sep 30, 2021 −$816.85K
Cash And Equivalents Q3 2021 · Sep 30, 2021 $635.12K
Stockholders Equity Q3 2021 · Sep 30, 2021 −$12.83M
Stockholders Equity Q3 2021 · Jun 30, 2021 −$16.4M
Stockholders Equity restated Q3 2021 · Mar 31, 2021 −$14.17M
Current Liabilities Q3 2021 · Sep 30, 2021 $343.88K
Total Liabilities Q3 2021 · Sep 30, 2021 $13.6M
Current Assets Q3 2021 · Sep 30, 2021 $767.23K
Total Assets Q3 2021 · Sep 30, 2021 $173.23M
Eps Diluted Q3 2021 · Sep 30, 2021 $0.17
Eps Diluted Q3 2021 · Sep 30, 2021 $0.15
Net Income Q3 2021 · Sep 30, 2021 $3.57M
Net Income restated Q3 2021 · Sep 30, 2021 $2.65M
Operating Income Q3 2021 · Sep 30, 2021 −$583.78K
Operating Income Q3 2021 · Sep 30, 2021 −$1.03M